Ramulu Poddutoori

USPTO Granted Patents = 13 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 135(Granted Patents)

Location History:

Andhra Pradesh, IN (2002 - 2005)
Hyderabad, IN (2004 - 2006)
Bengaluru, IN (2013)
Karnataka, IN (2016 - 2018)
Karimnagar, IN (2020 - 2021)
Telangana, IN (2021)

Company Filing History:

4 out of 2,096

Council of Scientific and Industrial Research

patents

4 out of 44

Aurigene Discovery Technologies Limited

Aurigene Oncology Limited

patents

Years Active: 2002-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331023 - Substituted heterocyclyl derivatives as CDK inhibitors (2025-06-17),

2. 11186576 - Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors (2021-11-30),

3. 11174232 - Substituted heterocyclyl derivatives as CDK inhibitors (2021-11-16),

4. 10894786 - Substituted pyrazole derivatives as selective CDK12/13 inhibitors (2021-01-19),

5. 10689347 - Substituted heterocyclyl derivatives as CDK inhibitors (2020-06-23),

6. 10011599 - Compounds and compositions as inhibitors of MEK (2018-07-03),

7. 9629836 - Compounds and compositions as inhibitors of MEK (2017-04-25),

8. 9227969 - Compounds and compositions as inhibitors of MEK (2016-01-05),

9. 8470878 - Heterocyclic sulfonamide derivatives (2013-06-25),

10. 7056913 - C8—linked pyrrolo[2,1-c][1,4]benzodiazepine-acridone/acridine hybrids (2006-06-06),

11. 6951853 - Process for preparing pyrrolo[2, 1-c] [1,4] benzodiazepine hybrids (2005-10-04),

12. 6800622 - Pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids useful as anti-cancer agents (2004-10-05),

13. 6362331 - Process for the preparation of antitumor agents (2002-03-26),

Title: Pioneering Innovator: Ramulu Poddutoori

Introduction:

Ramulu Poddutoori, a talented inventor based in Karnataka, India, has made remarkable contributions to the field of pharmaceuticals with his innovative work. With a total of 4 patents to his name, he is a key figure in the scientific community.

Latest Patents:

One of Ramulu Poddutoori's notable inventions is the development of compounds and compositions as inhibitors of MEK, demonstrated through compounds of formula I. This groundbreaking work showcases his expertise in creating novel solutions for medical advancements.

Career Highlights:

Ramulu Poddutoori is associated with Novartis AG, a renowned pharmaceutical company known for its cutting-edge research and development. His collaboration with Novartis AG has led to the successful implementation of his inventions in the industry, contributing significantly to the company's success.

Collaborations:

In his professional journey, Ramulu Poddutoori has closely worked with distinguished colleagues such as Mark G. Bock and Henrik Moebitz. Their collaborations have fostered a dynamic environment for innovation, leading to the creation of impactful solutions in the pharmaceutical sector.

Conclusion:

In conclusion, Ramulu Poddutoori's inventive spirit and dedication to advancing pharmaceutical research have positioned him as a trailblazer in the field. His valuable contributions, including his latest patents on MEK inhibitors, reflect his commitment to driving innovation and making a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.